Atritech
WATCHMAN™ Left Atrial Appendage Closure Device | Warfarin Therapy Alternative | Boston Scientific.
Enterprise value
$375m
Recent deals
Get premium to view all results
| Date | Investors | Amount | Round |
|---|---|---|---|
| - | investor investor investor investor investor | €0.0 | round |
| N/A | €0.0 | round | |
| investor investor investor | €0.0 | round | |
| investor investor investor investor | €0.0 | round | |
| investor investor investor | €0.0 | round | |
$375m Valuation: $375m | Acquisition | ||
| Total Funding | 000k | ||
Split Rock Partners(exited)
Vector Media Group(exited)
Prism Venture Management(exited)
SightLine Partners(exited)
Affinity Capital Management(exited)
Thoma Bravo(exited)
InterWest Partners(exited)
Charter Life Sciences(exited)
Astia(exited)
Affinity Capital Management(exited)
Thomas McNerney & Partners(exited)
Tullis Health Investors(exited)
Related Content
Analytics
Unlock the full power of analytics with a premium account
Track company size and historic growth
Track team composition and strength
Track website visits and app downloads
Tech stack
Tech stackLearn more about the technologies and tools that this company uses.
